← All organizations
Highest phase reached
Phase 2
First clinical trial
Mar 13, 2019Last known activity
Aug 1, 2024
Timeline
2010s
- Jun 1, 2018
GH Research Limited— Founded
Drugs by trial phase (2 distinct, 8 trials)
Phase 2 (2 own, 0 via acquisition)
Recent trials (11)
- NCT06511947Lead sponsorPhase 1Aug 1, 2024
- NCT05800860Lead sponsorPhase 2May 24, 2023
- NCT05839509Lead sponsorPhase 2Apr 6, 2023
- NCT05804708Lead sponsorPhase 2Mar 2, 2023
- NCT05753956Lead sponsorPhase 1Dec 22, 2022
- NCT05163691Study directorPhase 1Jun 21, 2021
- NCT05163691Lead sponsorPhase 1Jun 21, 2021
- NCT04698603Lead sponsorPhase 1/Phase 2Nov 12, 2019
- NCT04698603Study directorPhase 1/Phase 2Nov 12, 2019
- NCT04640831Study directorPhase 1Mar 13, 2019
- NCT04640831Lead sponsorPhase 1Mar 13, 2019
Details
- Founded
- Dublin, IE Jun 1, 2018
- Last known activity
- Aug 1, 2024